Recent Biden Administration Efforts On Drug Pricing: USPTO Notice Focuses On Eliminating Inconsistencies In USPTO/FDA Statements | MoFo Life Sciences

On July 29, 2022, the U.S. Patent and Trademark Office (USPTO) issued a Notice in the Federal Register clarifying the duty of disclosure that may keep patent practitioners up at night....

Related Keywords

United States ,American , ,Trademark Office ,Mofo Life Sciences ,Drug Administration ,Belcher Pharmaceuticals ,Mofo Life ,Federal Register ,Patent Trial ,Appeal Board ,President Biden ,Promoting Competition ,American Economy ,Information Received ,Statements Before ,Federal Circuit ,Chief Scientific Officer ,Patent Examining Procedure ,